What's bad for the heart is also bad for the brain
(Reuters Health) - People who have risk factors for heart disease like diabetes, high blood pressure and obesity may also be more likely...
Congo registers record 15 new Ebola cases in one day
Democratic Republic of Congo on Friday recorded 15 new confirmed cases of Ebola, the biggest one-day rise since the current outbreak was declared...
Alcohol, caffeine are common triggers of irregular heart rhythm
(Reuters Health) - The most common triggers of atrial fibrillation - an irregular heart rhythm that's a leading cause of stroke - are...
Drinking scalding-hot tea may increase esophagus cancer risk
(Reuters Health) - Tea drinkers who love a scalding-hot cup of the beverage may want to let it cool down a bit to...
Red Cross says it sees conditions for humanitarian work in Venezuela
Venezuela has met the necessary conditions for the Red Cross to carry out humanitarian work in the South American nation, the president of...
Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges
Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid...
Fresenius Medical Care says U.S. settlement will not affect 2019, 2020 results
Fresenius Medical Care AG said that a $231.7 million U.S. settlement reached on Friday to resolve bribery allegations would have no impact on...
U.S judge strikes down rule allowing 'skimpy' health insurance plans
A federal judge on Thursday stuck down a Trump administration rule aimed at enabling millions of Americans to buy skimpy health insurance plans...
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
AstraZeneca Plc will pay up to $6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer,...
EMA panel recommends approval of Bluebird Bio's first gene therapy
A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic...
Shares in Galapagos jump 15 percent after arthritis drug results
Shares in Belgian drugmaker Galapagos surged nearly 16 percent on Friday after the company said it had seen positive results from several safety...
Bayer shares sag after U.S. jury verdict in Roundup cancer trial
Bayer AG shares sank to their lowest in almost seven years on Thursday after a U.S. jury awarded $80 million to a man...
Exclusive: Magellan Health nears board deal with hedge fund Starboard Value - sources
U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc is nearing an agreement with Starboard Value LP to expand the size of...
